Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcus Biosciences, Inc. Common Stock
(NY:
RCUS
)
20.28
-0.93 (-4.38%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences, Inc. Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
52 Stocks Moving In Wednesday's Mid-Day Session
↗
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...
Via
Benzinga
Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others
↗
May 11, 2022
Roche isn't the only company working on an anti-TIGIT molecule.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
May 11, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
May 11, 2022
Good morning and welcome back for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
34 Stocks Moving in Wednesday's Pre-Market Session
↗
May 11, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share.
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
May 10, 2022
From
Arcus Biosciences
Via
Business Wire
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
↗
May 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Arcus Posts Encouraging Data For Domvanalimab-Based Regimes In Lung Cancer Settings
↗
May 10, 2022
Via
Benzinga
Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
May 09, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For May 9, 2022
↗
May 09, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Via
Benzinga
Arcus Biosciences's Earnings Outlook
↗
May 06, 2022
Arcus Biosciences (NYSE:RCUS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Arcus...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 05, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Arcus Biosciences to Report First Quarter 2022 Financial Results and Pipeline Update
April 26, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 26, 2022
From
Arcus Biosciences
Via
Business Wire
4 Undervalued Biotech Stocks to Add to Your Buy List
↗
April 20, 2022
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.
Via
InvestorPlace
Arcus Biosciences Announces New Employment Inducement Grants
April 11, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
April 11, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 05, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
↗
April 05, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 05, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
↗
April 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
↗
April 05, 2022
Gainers System1, Inc. (NYSE: SST) rose 37.5% to $22.70 in pre-market trading as the company reported a 48% year-over-year surge in Q4 sales and issued strong sales forecast....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
April 05, 2022
Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Arcus Biosciences Announces New Employment Inducement Grants
March 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
February 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
88 Biggest Movers From Yesterday
↗
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Recap: Arcus Biosciences Q4 Earnings
↗
February 23, 2022
Arcus Biosciences (NYSE:RCUS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
February 23, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For February 23, 2022
↗
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
